ENGOT-cx1/BGOG-cx1
Trial Description:
Randomized double-blind Phase II study comparing carboplatin + paclitaxel with or without concomitant and maintenance Nintedanib in advanced or recurrent cervical carcinoma
Lead Cooperative Group:
Trial Number:
Disease Site:
Cervical
Trial Status:
Closed to Recruitment
Contact person:
ivergote